Heart failure biomarkers at point-of-care: current utilization and future potential (Q38187750)

30 August 2017

Heart failure biomarkers at point-of-care: current utilization and future potential (English)

1 reference

30 August 2017

0 references

0 references

Eric S Christenson

1

1 reference

30 August 2017

Paul O Collinson

series ordinal

2

1 reference

30 August 2017

Christopher R Defilippi

series ordinal

3

1 reference

30 August 2017

Robert H Christenson

series ordinal

4

1 reference

30 August 2017

13 February 2014

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

30 August 2017

1 reference

30 August 2017

14

1 reference

30 August 2017

2

1 reference

30 August 2017

185-197

1 reference

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

30 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Myocardial recovery and the failing heart: myth, magic, or molecular target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Analytical characteristics of high-sensitivity cardiac troponin assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Brain and other natriuretic peptides: molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

A multiplexed point-of-care assay for C-reactive protein and N-terminal pro-brain natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Natriuretic peptides: physiologic and analytic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Comparison of analytical performance of two single-step measurement devices of B-type natriuretic Peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Cardiorenal biomarkers in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Investigating suspected heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

B-type natriuretic peptide-guided heart failure therapy: A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Amino-terminal pro-B-type natriuretic peptide: analytic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Effect of lipopolysaccharide, cytokines, and catecholamines on brain natriuretic peptide release from human myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Clinical utility of natriuretic peptides in left ventricular failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Troponin elevation in heart failure prevalence, mechanisms, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Biomarker changes during acute heart failure treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Growth-differentiation factor-15 in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Growth-differentiation factor-15 improves reclassification for the diagnosis of heart failure with normal ejection fraction in morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Newer biomarkers in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Personalizing biomarker strategies in heart failure with galectin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Equal performance of novel N-terminal proBNP (Cardiac proBNP®) and established BNP (Triage BNP®) point-of-care tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Diagnostic accuracy of a point-of-care troponin I assay for acute myocardial infarction within 3 hours after presentation in early presenters to the emergency department with chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

The use of B-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

A clinician's experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Left ventricular dysfunction screening in hypertensive patients with N-terminal pro-B-type natriuretic peptide and electrocardiogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

B-type natriuretic peptide in the evaluation and management of dyspnoea in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Primary results of the HABIT Trial (heart failure assessment with BNP in the home).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Assessment of using fingerstick blood sample with i-STAT point-of-care device for cardiac troponin I assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Cardiac markers: a clear cause for point-of-care testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement alone in the RATPAC trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.882772

10.1586/14737159.2014.882772

21 January 2018

Identifiers

DOI

1 reference

release_vqjloq52tzeolhyqtqcv5o3i7y

30 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vqjloq52tzeolhyqtqcv5o3i7y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference